Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2025: Beyond Gene Sequencing, New Diagnostic Technologies Emerge - ResearchAndMarkets.com

The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization" has been added to ResearchAndMarkets.com's offering.

As antimicrobial resistance (AMR) continues to pose a significant threat to global health, innovative diagnostic technologies are taking center stage in the effort to mitigate this challenge. These advancements could potentially address the resistance dilemma even in the face of delayed development of new antibiotics. Cutting-edge diagnostic tools, surpassing traditional gene sequencing methods, are being researched and developed to seize the expanding market opportunities within this vital healthcare domain.

In an extensive analysis, the publisher sheds light on the technological landscape, covering a variety of sophisticated approaches for diagnosing pathogens and infections. We have pinpointed six major pathogen-related opportunities, underscoring their importance in the diagnosis and treatment of infectious diseases. Furthermore, we offer detailed market forecasts to aid stakeholders in navigating this rapidly evolving field.

The study profiles over 30 leading companies, from industry giants to emerging innovators, all dedicated to advancing diagnostic solutions in the face of AMR. These entities are leveraging new technologies to enhance the accuracy, efficiency, and speed of pathogen detection, which is crucial in managing infections and curbing the spread of resistance.

With AMR limiting the efficacy of current antibiotics, the role of diagnostics becomes even more critical. Enhanced diagnostic tools not only aid in identifying appropriate treatments faster but also enable more precise use of antibiotics, thereby contributing to the global effort to fight resistance.

Current and future diagnostic technologies promise healthcare professionals more robust options in the ongoing battle against AMR. By expanding the avenues for early detection and precise pathogen identification, these technologies are essential in managing infectious disease threats and influencing treatment outcomes.

As the world continues to grapple with AMR and its implications on public health, the development and implementation of advanced diagnostic solutions stand as a beacon of hope. The strategic insights and comprehensive market forecasts provided in the publisher's study serve as valuable resources for stakeholders aiming to capitalize on the innovations reshaping the fight against infectious diseases.

Key Topics Covered:

1 Market Guides

1.1 Antimicrobial Resistance - Strategic Situation Analysis

1.2 Guide for Executives and Business Development Staff

1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 The Threat and Opportunity of Antimicrobial Resistance

2.2 Defining the Opportunity

2.2.1 Revenue Market Size

2.3 Methods and Sources

2.3.1 Methodology

2.3.2 Sources

2.3.3 Authors

2.4 Perspective: Healthcare and the IVD Industry

2.4.1 Global Healthcare Spending

2.5 Spending on Diagnostics

2.5.1 Important Role of Insurance for Diagnostics

3 Overview of a Dynamic Market

3.1 Players in a Dynamic Market

3.1.1 Diagnostic Test Developer

3.1.2 Instrumentation Supplier

3.1.3 Chemical/Reagent Supplier

3.1.4 Pathology Supplier

3.1.5 Independent Clinical Laboratory

3.1.6 Public National/regional Laboratory

3.1.7 Hospital Laboratory

3.1.8 Physicians Office Lab (POLS)

3.1.9 Audit Body

3.1.10 Certification Body

3.2 Understanding Antimicrobial Resistance

3.2.1 What is Antimicrobial Resistance (AMR)

3.2.2 Bacteria and Other Microbes

3.2.3 The History of Antibiotics

3.2.4 The Role of Animal Husbandry

3.2.5 The Implications of Horizontal Transfer

3.2.6 The Threat of AMR

3.3 The Changing Road to New Antibiotics & Technologies

3.4 The Key Role of Diagnostics in AMR

4 The Market Opportunity of AMR

4.1 The Key Large Market Opportunities in AMR

4.1.1 Streptococcus Pneumoniae (DRSP)

4.1.2 Campylobacter (DRC)

4.1.3 Clostridium Difficile (CD)

4.1.4 Staphylococcus aureus (MRSA)

4.1.5 Neisseria gonorrhoeae (DRNG)

4.1.6 Salmonella (DRNTS)

4.2 Diagnostic Technology Development Opportunities

4.2.1 What's Wrong with Microbiology

4.2.2 The Features Battleground of Infectious Disease Diagnostics

4.2.3 Multiplex vs. POC/Rapid

4.2.4 The Miracle of Genetics

4.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation

4.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing.

4.2.7 Markers of Resistance.

4.2.8 What Happens to the Microbiology Lab?

5 Antibiotic Resistance Diagnostics Recent Developments

5.1 Antibiotic Resistance Recent Developments

5.1.1 Importance of These Developments

5.1.2 How to Use This Section

5.2 FDA Clears New bioMerieux Diagnostic System and Panel

5.3 Selux Diagnostics Phenotyping System Gets FDA Approval

5.4 New diagnostics to tackle drug resistant infections

5.5 Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Infectious Disease Panels

5.6 Three companies join forces to tackle antimicrobial resistance (AMR)

5.7 T2 Biosystems Exercises BARDA Option

5.8 OpGen to Ramp up Use of Acuitas AMR Gene Panel

5.9 BD Partners With Pfizer, Wellcome to Study AMR Dx

5.10 Sepsis Test Developers Accelerate Plans

5.11 OpGen Receives FDA Clearance for AMR Panel

5.12 Visby Medical - Rapid Uptake of Handheld PCR Test for STIs

5.13 MicroGenDx, OrthoKey Clinic and OrthoKey Surgery

5.14 BioMerieux Receives CE Mark for Vitek Clinical Microbiology System

5.15 Hologic to Acquire Mobidiag

5.16 Campylobacter strains exchange genes

5.17 Disinfection spreads antimicrobial resistance

5.18 Molzym, Fraunhofer Developing Rapid Sepsis Dx

5.19 Illumina, IDbyDNA Build NGS-Based Respiratory Panel

5.20 Accelerate Diagnostics Expands AMR Testing

5.21 Rapid diagnostics linked to optimal antibiotics

5.22 Visby Medical Wins AMR Diagnostic Competition

5.23 DNAe Technology SARS-CoV-2 Sequences

5.24 Infections with foodborne bacteria becoming harder to treat

5.25 Dust is sharing antibiotic resistance genes

6 Key AMR Diagnostics Companies

6.1 1928 Diagnostics

6.2 Abacus Diagnostica

6.3 Abbott Laboratories

6.4 Accelerate Diagnostics

6.5 ADT Biotech

6.6 Beckman Coulter Diagnostics

6.7 Becton, Dickinson and Company

6.8 Binx Health

6.9 bioMerieux Diagnostics

6.10 Bio-Rad Laboratories, Inc.

6.11 Cepheid (Danaher)

6.12 Curetis N.V. / Curetis GmbH

6.13 Day Zero Diagnostics.

6.14 Enzo Biochem

6.15 Eurofins Scientific

6.16 Fusion Genomics.

6.17 GeneFluidics

6.18 Genetic Signatures

6.19 Great Basin Corporation

6.20 Hologic

6.21 Hutman Diagnostics

6.22 Inflammatix

6.23 Linear Diagnostics.

6.24 Lumos Diagnostics

6.25 Millipore Sigma

6.26 OpGen

6.27 Ortho Clinical Diagnostics

6.28 Perkin Elmer

6.29 Qiagen

6.30 Roche Molecular Diagnostics

6.31 SeLux Diagnostics

6.32 Sense Biodetection

6.33 Siemens Healthineers

6.34 Sysmex

6.35 Thermo Fisher Scientific Inc.

6.36 Visby Medical

7 The Global Market for Antimicrobial Resistance Diagnostics

7.1 Global Market Overview by Country

7.2 Global Market by Technology - Overview

7.3 Global Market by Technology - Overview

8 Global Antibiotic Resistance Diagnostic Markets - By Pathogen

8.1 Drug Resistant Streptococcus Pneumoniae - DRSP

8.2 Drug Resistant Campylobacter - DRC

8.3 Clostridium Difficile - CD

8.4 Methicillin Resistant Staphylococcus Aureus - MRSA

8.5 Drug Resistant Neisseria Gonorrhoeae - DRNG

8.6 Drug Resistant Salmonella - DRNTS

9 Global Antibiotic Resistance Diagnostic Markets - by Technology

9.1 Microbiology Culture

9.2 Immunoassay

9.3 PCR

9.4 NGS

9.5 Mass Spectrometry - MS

9.6 Rapid and Point of Care - Rapid/POC

10 Vision of the Future of AMR Diagnostics

11 Appendices

11.1 United States Medicare System: Clinical Laboratory Fees Schedule

For more information about this report visit https://www.researchandmarkets.com/r/fuzpmi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250616314674/en/